Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayush Pant

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Neuro-Oncology|February 25, 2020
Understanding innate immune response in glioblastoma in search of a way forwardAyush Pant, Michael Lim
Cell Reports. Medicine|December 21, 2022
Advances in co-opting anti-depressant drugs in glioma therapyAyush Pant, Michael Lim
Neuro-Oncology|October 9, 2021
Checkpoint blockade in recurrent meningiomas: Lessons for future managementAyush Pant, Michael Lim
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2023
Overcoming EGFR inhibitor resistance in Glioblastoma by targeting co-amplified genesAyush Pant, Michael Lim
Cancers|February 25, 2023
CAR-T Therapy in GBM: Current Challenges and Avenues for ImprovementAyush Pant, Michael Lim
The Journal of Clinical Investigation|August 15, 2022
Supercharged chimeric antigen receptor T cells in solid tumorsAyush Pant, Christopher M Jackson
Current Oncology Reports|November 3, 2020
Alternative Checkpoints as Targets for ImmunotherapyAyush Pant, Ravi Medikonda, Michael Lim
Advances in Experimental Medicine and Biology|January 1, 2023
Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord TumorsRavi Medikonda, Ayush Pant, Michael Lim
Cancer Gene Therapy|October 9, 2019
CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with gliomaLuqing Tong, Jiabo Li, John Choi, et al.
Oncoimmunology|July 22, 2021
Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastomaJohn Choi, Ayush Pant, Ravi Medikonda, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Neuro-Oncology|February 25, 2020
Understanding innate immune response in glioblastoma in search of a way forwardAyush Pant, Michael Lim
Cell Reports. Medicine|December 21, 2022
Advances in co-opting anti-depressant drugs in glioma therapyAyush Pant, Michael Lim
Neuro-Oncology|October 9, 2021
Checkpoint blockade in recurrent meningiomas: Lessons for future managementAyush Pant, Michael Lim
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2023
Overcoming EGFR inhibitor resistance in Glioblastoma by targeting co-amplified genesAyush Pant, Michael Lim
Cancers|February 25, 2023
CAR-T Therapy in GBM: Current Challenges and Avenues for ImprovementAyush Pant, Michael Lim
The Journal of Clinical Investigation|August 15, 2022
Supercharged chimeric antigen receptor T cells in solid tumorsAyush Pant, Christopher M Jackson
Current Oncology Reports|November 3, 2020
Alternative Checkpoints as Targets for ImmunotherapyAyush Pant, Ravi Medikonda, Michael Lim
Advances in Experimental Medicine and Biology|January 1, 2023
Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord TumorsRavi Medikonda, Ayush Pant, Michael Lim
Cancer Gene Therapy|October 9, 2019
CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with gliomaLuqing Tong, Jiabo Li, John Choi, et al.
Oncoimmunology|July 22, 2021
Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastomaJohn Choi, Ayush Pant, Ravi Medikonda, et al.
Pageof 3